Aptitude Metrix COVID Test Receives FDA 510(k) Clearance
Carlsbad, California, USA, September 17, 2026 Aptitude Medical Systems has announced that the U.S. Food and Drug Administration (FDA)...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Carlsbad, California, USA, September 17, 2026 Aptitude Medical Systems has announced that the U.S. Food and Drug Administration (FDA)...
CHICAGO — September 8, 2026 GE HealthCare announced that its new StarGuide GX digital 4D CZT SPECT/CT system is...
Amsterdam, the Netherlands, September 3, 2026 Royal Philips has introduced the eV14-2v transvaginal transducer, a new single-transducer solution designed...
NEW YORK, September 2, 2026 Intelligent Bio Solutions Inc. has reported strong performance results for its Intelligent Fingerprinting Drug...
Chicago, Ill. – August 28, 2026 GE HealthCare announced three additions to its Vivid™ cardiovascular ultrasound portfolio — Vivid...
Chicago, Illinois, USA, Aug 26, 2026 Tempus AI, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance...
IRVINE, Calif., August 25, 2026 Masimo, a Danaher company focused on specialty diagnostics and patient monitoring technologies, announced that...
Needham, Massachusetts, USA,August 20, 2026 Evolved By Nature, Inc. announced that its programmable peptide platform has been used in...
Redwood City, California, August 20, 2026 Galvanize Therapeutics, Inc. has announced new peer-reviewed evidence suggesting that its Aliya® pulsed...
Menlo Park, California, August 20, 2026 Maverix Medical has announced that the U.S. Food and Drug Administration (FDA) granted...
